You have 9 free searches left this month | for more free features.

Serotonin Reuptake Inhibitor

Showing 1 - 25 of 8,603

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Major Depressive Disorder With Anhedonia and Inadequate Response

Not yet recruiting
  • Depressive Disorder, Major
  • No Intervention
  • (no location specified)
Apr 24, 2023

Haemorrhage Between Vortioxetine Tablet Treatment and Selective

Not yet recruiting
  • Major Depressive Disorder
  • Vortioxetine Tablet
  • SSRI
  • (no location specified)
Jun 28, 2023

Selective Serotonin Reuptake Inhibitor on Cognition, Sexual

Recruiting
  • Menopause
  • Hormone replacement therapy
  • Selective serotonin reuptake inhibitors
  • São Bernardo do Campo, SP, Brazil
    Centro de Atenção Integral à Saúde da Mulher
Jan 20, 2022

Major Depressive Disorder Who Have HadInadequate Response

Terminated
  • Depressive Disorder, Major
  • Standard of Care (SOC)
  • San Francisco, California
  • +3 more
Dec 6, 2022

Geriatric Depression, Cognitive Impairment Trial in Beijing (Selective Serotonin Reuptake Inhibitor(SSRIs,Fluoxetine,

Recruiting
  • Geriatric Depression
  • Cognitive Impairment
  • Selective Serotonin Reuptake Inhibitor(SSRIs,Fluoxetine, paroxetine, fluvoxamine, sertraline, citalopram, escitalopram)
  • Beijing, China
    Beijing Anding Hospital Affiliated to Capital Medical University
Oct 18, 2022

Depressive Disorder, Major, Treatment Resistant Depression, Melancholia Trial in Ghent (device, behavioral, drug)

Recruiting
  • Depressive Disorder, Major
  • +2 more
  • aiTBS
  • +2 more
  • Ghent, East-Flanders, Belgium
    University Hospital Ghent
Dec 6, 2022

Depression in Old Age, Fragility Fracture Trial in Winston-Salem (Duloxetine 30 mg)

Not yet recruiting
  • Depression in Old Age
  • Fragility Fracture
  • Duloxetine 30 mg
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences
May 9, 2023

Retinal Nerve Fiber Layer in First Episode Depressive Patients

Enrolling by invitation
  • Unipolar Depression
    • Diyarbakır, Turkey
      Sağlık Bilimleri Üniversitesi Gazi Yaşargil Tranining and Resear
    Mar 16, 2021

    None (i.e. Healthy Volunteers) Trial in Ottawa (Levomilnacipran, Duloxetine, Placebos)

    Active, not recruiting
    • None (i.e. Healthy Volunteers)
    • Ottawa, Ontario, Canada
      Institute of Mental Health Research, Royal Ottawa Mental Health
    Oct 5, 2021

    SSRI's and the Rate of Progression From MCI to Dementia

    Recruiting
    • Mild Cognitive Impairment
    • +2 more
    • Columbus, Ohio
      The Ohio State University
    Sep 8, 2021

    PTSD Trial in United States (Selective serotonin reuptake inhibitor, Serotonin-norepinephrine reuptake inhibitor, Written

    Recruiting
    • PTSD
    • Selective serotonin reuptake inhibitor
    • +2 more
    • North Little Rock, Arkansas
    • +15 more
    Aug 2, 2022

    Meniere Disease Trial in Charleston (Venlafaxine, Placebo oral tablet)

    Recruiting
    • Meniere Disease
    • Charleston, South Carolina
      Medical Univeristy of South Carolina
    Dec 2, 2021

    Risk Factors for AD-Associated Switch to Mania

    Completed
    • Bipolar Disorder
    • Selective Serotonin Reuptake Inhibitors (SSRI), Serotonin-Norepinephrine Reuptake Inhibitor( SNRI), and Tricyclics.
    • Barcelona, Catalonia, Spain
      Hospital Clinic Barcelona
    Nov 17, 2021

    Neurodevelopmental Disorders, Autism, Autism Spectrum Disorder Trial in Canada (Sertraline, Placebo)

    Not yet recruiting
    • Neurodevelopmental Disorders
    • +25 more
    • Calgary, Alberta, Canada
    • +6 more
    Oct 11, 2023

    Tibial Plateau Fracture, Pain, Postoperative Trial in Boston, Valhalla (Duloxetine, Placebo, Standard of care (SOC) for tibial

    Not yet recruiting
    • Tibial Plateau Fracture
    • Pain, Postoperative
    • Boston, Massachusetts
    • +1 more
    Aug 6, 2022

    Depression, MDD, Dysthymic Disorder Trial in Indianapolis (behavioral, drug, other)

    Completed
    • Depression
    • +7 more
    • Beating the Blues (BtB)
    • +3 more
    • Indianapolis, Indiana
      IUPUI Department of Psychology
    Aug 30, 2021

    Depressive Disorder, Major Trial in Worldwide (Esketamine 28 mg, Esketamine 56 mg, Esketamine 84 mg)

    Completed
    • Depressive Disorder, Major
    • Esketamine 28 mg
    • +6 more
    • Ciudad Autonoma de Buenos Aires, Argentina
    • +170 more
    Sep 13, 2022

    Depressive Disorder, Major Trial in Worldwide (Seltorexant, Placebo)

    Recruiting
    • Depressive Disorder, Major
    • San Diego, California
    • +26 more
    Aug 17, 2022

    Hypercapnia, Ventilatory Depression Trial in West Bend (Placebo and Oxycodone, Paroxetine and Oxycodone, Escitalopram and

    Not yet recruiting
    • Hypercapnia
    • Ventilatory Depression
    • Placebo and Oxycodone
    • +2 more
    • West Bend, Wisconsin
      Spaulding Clinical Research
    Jul 20, 2022

    Obsessive Compulsive Disorder Trial in Hamilton (Topiramate, )

    Completed
    • Obsessive Compulsive Disorder
    • Hamilton, Ontario, Canada
      MacAnxiety Research Centre
    Aug 31, 2020

    Pulmonary Arterial Hypertension Trial in Dallas (Fluoxetine)

    Completed
    • Pulmonary Arterial Hypertension
    • Dallas, Texas
      UT Southwestern Medical Center
    Jun 24, 2020

    Stroke Trial in Bordeaux, Toulouse (Fluoxetine, Placebo, fMRI)

    Unknown status
    • Stroke
    • Bordeaux, France
    • +1 more
    Jul 29, 2020

    OCD Trial (N-Acetylcysteine, )

    Terminated
    • Obsessive-Compulsive Disorder
    • (no location specified)
    Mar 31, 2020

    Stroke, Ischemic Trial in White Plains (Administration of SSRI escitalopram, Paired Associative stimulation, Administration of

    Withdrawn
    • Stroke, Ischemic
    • Administration of SSRI escitalopram
    • +2 more
    • White Plains, New York
      Burke Neurological Institute
    Jul 19, 2021